In prostate cancer, excessive ROS induce NFE2L1 activation and regulate downstream antioxidant genes, such as peroxiredoxin 1 (Prx-1) and thioredoxin 1 (Txn-1), which compensate for oxidative stress and maintain redox homeostasis [105]. Here, NFE2L1 is linked to prostate carcinoma.